The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells

Molecular and Cellular Biology

Volumn 34, Issue 23, 2014, Pages 4216-4231

  Llobet Navas, David ^a   Rodriguez Barrueco, Ruth ^a   de La Iglesia Vicente, Janis ^a   Olivan, Mireia ^a   Castro, Veronica ^a   Saucedo Cuevas, Laura ^a   Marshall, Netonia ^b   Putcha, Preeti ^b   Castillo Martin, Mireia ^a   Bardot, Evan ^a   Ezhkova, Elena ^a   Iavarone, Antonio ^b   Cordon Cardo, Carlos ^a   Silva, Jose M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDC25A PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 16; MICRORNA 424/503; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN BCL 2; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CDC25A PROTEIN, HUMAN; ESTROGEN RECEPTOR; IGF1 PROTEIN, HUMAN; LY2109761; MIRN424 MICRORNA, HUMAN; MIRN503 MICRORNA, HUMAN; PROGESTERONE RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; PYRAZOLE DERIVATIVE; PYRROLE DERIVATIVE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; BREAST EPITHELIUM; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FEMALE; GENE CONTROL; GENE DELETION; GENE REPRESSION; HISTONE PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KNOCKOUT MOUSE; MAMMARY GLAND; METABOLISM; UDDER;

ANIMALS; APOPTOSIS; CDC25 PHOSPHATASES; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PROMOTER REGIONS, GENETIC; PYRAZOLES; PYRROLES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84909619836     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00611-14     Document Type: Article

References (42)

1. Sundqvist A, Ten Dijke P, van Dam H. 2012. Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res. 14:204. http://dx.doi.org/10.1186 /bcr3066.
2. Howard BA, Gusterson BA. 2000. Human breast development. J. Mammary Gland Biol. Neoplasia 5:119-137. http://dx.doi.org/10.1023/A:1026487120779.
3. Macias H, Hinck L. 2012. Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 1:533-557. http://dx.doi.org/10.1002/wdev.35.
4. Massague J. 2008. TGFbeta in cancer. Cell 134:215-230. http://dx.doi.org /10.1016/j.cell.2008.07.001.
5. Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM, Stampfer MR. 1997. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17:2458-2467.
6. Iavarone A, Massague J. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387:417-422. http://dx.doi.org/10.1038/387417a0.
7. Chen CR, Kang Y, Massague J. 2001. Defective repression of c-myc in breast cancer cells:Aloss at the core of the transforming growth factor beta growth arrest program. Proc. Natl. Acad. Sci. U. S. A. 98:992-999. http: //dx.doi.org/10.1073/pnas.98.3.992.
8. Kim WY, Sharpless NE. 2006. The regulation of INK4/ARF in cancer and aging. Cell 127:265-275. http://dx.doi.org/10.1016/j.cell.2006.10.003.
9. Boutros R, Lobjois V, Ducommun B. 2007. CDC25 phosphatases in cancer cells: key players?Goodtargets? Nat. Rev. Cancer 7:495-507. http://dx.doi.org /10.1038/nrc2169.
10. Iavarone A, Massague J. 1999. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol. Cell. Biol. 19:916-922.
11. Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF, Kiyokawa H. 2005. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol. Cell. Biol. 25:3338-3347. http://dx .doi.org/10.1128/MCB.25.8.3338-3347.2005.
12. Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, Emanueli C. 2011. Deregulation of micro- RNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123:282-291. http://dx.doi.org/10.1161/CIRCULATIONAHA.110 .952325.
13. Zhao H, Wang J, Gao L, Wang R, Liu X, Gao Z, Tao Z, Xu C, Song J, Ji X, Luo Y. 2013. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke 44:1706-1713. http://dx.doi.org/10.1161/STROKEAHA.111.000504.
14. Sarkar S, Dey BK, Dutta A. 2010. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol. Biol. Cell 21:2138- 2149. http://dx.doi.org/10.1091/mbc.E10-01-0062.
15. Llobet-Navas D, Rodriguez-Barrueco R, Castro V, Ugalde AP, Sumazin P, Jacob-Sendler D, Demircan B, Castillo-Martin M, Putcha P, Marshall N, Villagrasa P, Chan J, Sanchez-Garcia F, Pe'er D, Rabadan R, Iavarone A, Cordon-Cardo C, Califano A, Lopez-Otin C, Ezhkova E, Silva JM. 2014. The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev. 28:765-782. http://dx.doi.org/10.1101/gad.237404.114.
16. Clarke RB, Howell A, Potten CS, Anderson E. 1997. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57:4987-4991.
17. Grimm SL, Rosen JM. 2006. Stop! In the name of transforming growth factor-beta: keeping estrogen receptor-alpha-positive mammary epithelial cells from proliferating. Breast Cancer Res. 8:106. http://dx.doi.org/10 .1186/bcr1520.
18. Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH. 2005. Proliferation of estrogen receptor-alphapositive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Am. J. Pathol. 167:409-417. http://dx.doi.org /10.1016/S0002-9440(10)62985-9.
19. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D. 2000. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 96:3392-3398.
20. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. 2006. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res. 34:e9. http://dx.doi.org/10.1093/nar/gnj009.
21. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e179. http://dx.doi.org/10.1093/nar/gni178.
22. Shehata M, Teschendorff A, Sharp G, Novcic N, Russell A, Avril S, Prater M, Eirew P, Caldas C, Watson CJ, Stingl J. 2012. Phenotypic and functional characterization of the luminal cell hierarchy of the mammary gland. Breast Cancer Res. 14:R134. http://dx.doi.org/10.1186/bcr3334.
23. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M, Jr, Jungkamp AC, Munschauer M, Ulrich A, Wardle GS, Dewell S, Zavolan M, Tuschl T. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PARCLIP. Cell 141:129-141. http://dx.doi.org/10.1016/j.cell.2010.03.009.
24. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X. 2008. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 36:5391-5404. http://dx.doi.org/10.1093 /nar/gkn522.
25. Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT. 2010. The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J. Mol. Biol. 402:491-509. http://dx.doi.org/10.1016/j.jmb.2010.07.051.
26. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27:91-105. http://dx.doi.org/10.1016/j.molcel.2007.06 .017.
27. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20. http://dx.doi.org/10.1016/j.cell.2004.12.035.
28. Shirdel EA, Xie W, Mak TW, Jurisica I. 2011. NAViGaTing the micronome- using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 6:e17429. http://dx.doi .org/10.1371/journal.pone.0017429.
29. Karakas B, Weeraratna A, Abukhdeir A, Blair BG, Konishi H, Arena S, Becker K, Wood W, III, Argani P, De Marzo AM, Bachman KE, Park BH. 2006. Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells. Oncogene 25:5561-5569. http://dx.doi.org/10.1038/sj.onc .1209540.
30. Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 30:256-268. http: //dx.doi.org/10.1016/S1046-2023(03)00032-X.
31. Nilsson I, Hoffmann I. 2000. Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res. 4:107-114. http://dx.doi.org/10.1007 /978-1-4615-4253-7_10.
32. Nguyen AV, Pollard JW. 2000. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127:3107-3118.
33. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. 2003. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am. J. Pathol. 163: 1539-1549. http://dx.doi.org/10.1016/S0002-9440(10)63510-9.
34. Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, Babb JS, Lonning SM, DeWyngaert JK, Formenti SC, Barcellos-Hoff MH. 2011. TGFbeta1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin. Cancer Res. 17:6754-6765. http://dx.doi.org/10.1158/1078-0432.CCR-11-0544.
35. Melisi D, Ishiyama S, Sclabas GM, Fleming JB, Xia Q, Tortora G, Abbruzzese JL, Chiao PJ. 2008. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol. Cancer Ther. 7:829-840. http://dx.doi.org/10.1158/1535-7163.MCT-07-0337.
36. Johnson K, Kirkpatrick H, Comer A, Hoffmann FM, Laughon A. 1999. Interaction of Smad complexes with tripartite DNA-binding sites. J. Biol. Chem. 274:20709-20716.
37. Ameres SL, Zamore PD. 2013. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell. Biol. 14:475-488. http://dx.doi.org/10.1038 /nrm3611.
38. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840. http://dx.doi.org/10.1038/nature09267.
39. Aqeilan RI, Calin GA, Croce CM. 2010. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 17:215-220.
40. Aqeilan RI, Calin GA, Croce CM. 2010. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 17:215-220. http://dx.doi.org/10.1038/cdd.2009.69.
41. Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, Sottoriva A, Zhao Y, Hirst M, Armisen J, Miska EA, Chin SF, Provenzano E, Turashvili G, Green A, Ellis I, Aparicio S, Caldas C. 2013. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497: 378-382. http://dx.doi.org/10.1038/nature12108.
42. Ray D, Terao Y, Fuhrken PG, Ma ZQ, DeMayo FJ, Christov K, Heerema NA, Franks R, Tsai SY, Papoutsakis ET, Kiyokawa H. 2007. Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instability. Cancer Res. 67:984-991. http://dx.doi.org/10 .1158/0008-5472.CAN-06-3927.